Join us for an exclusive webinar where senior APAC M&A leaders discussed the emerging trends reshaping the dealmaking landscape.

At the final Capital for Cures spring summit in Frankfurt, biotech founders and investors explored how to close expectation gaps, build trust and secure sustainable funding in a volatile market.

Step inside the deal room with M&A advisors who specialize in middle-market transactions.

Insights from the Capital for Cures Summit in London.

The future of AI-powered dealmaking lies in intelligent systems that don’t just inform decisions — they take action.

Firsthand insights on what it takes to finance breakthrough science in a shifting biotech landscape. 

Sectoral Asset Management specializes in public equity and venture capital investments in the healthcare sector. The firm chose SS&C Intralinks InvestorVisionTM to streamline the reporting process for its fund administrators and global investors.